Results
21
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
21 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ORAD | ₪0.73 | -0.9% | 37.4% | ₪68.6m | n/a | PE10.1x | n/a | n/a | ||
NXSN | ₪72.00 | -1.8% | 74.5% | ₪5.8b | n/a | PE27.4x | n/a | 0.9% | ||
ORTC | ₪8.46 | 0% | -40.6% | ₪37.8m | n/a | PS7.8x | n/a | 5.9% | ||
TLSY | ₪181.60 | 2.3% | -28.3% | ₪1.6b | n/a | PE16.4x | n/a | 7.6% | ||
EEAM-M | ₪0.11 | -18.5% | -93.9% | ₪10.4m | n/a | PS1x | n/a | 1,572.3% | ||
ARD | ₪48.92 | 0.02% | -20.6% | ₪1.2b | n/a | PE14.7x | n/a | 3.5% | ||
MCRNT | ₪3.15 | -0.1% | 75.0% | ₪29.5m | n/a | PS8.9x | n/a | 0% | ||
UNIT | ₪28.50 | 3.1% | -7.8% | ₪396.2m | n/a | PE8.9x | n/a | 8.1% | ||
DNA | ₪1.10 | 5.3% | 49.6% | ₪135.6m | n/a | PE9x | n/a | n/a | ||
CLAB | ₪12.39 | 1.6% | -8.4% | ₪105.1m | n/a | PE6.7x | n/a | n/a | ||
SVRE | ₪0.018 | 0% | -97.7% | ₪12.2m | n/a | PS7x | E31.8% | n/a | ||
STG | ₪52.13 | -2.8% | 21.2% | ₪242.4m | n/a | PE12.7x | n/a | 0% | ||
NYAX | ₪140.00 | -1.6% | 41.5% | ₪5.1b | ₪130.89 | PS4.9x | E122.6% | n/a | ||
PCBT | ₪8.69 | -0.1% | 109.4% | ₪624.3m | n/a | PE32.1x | n/a | 2.3% | ||
SNCM | ₪1.33 | 4.3% | 22.0% | ₪288.3m | n/a | PE7.2x | n/a | 6.9% | ||
ICON | ₪4.44 | 0.8% | -8.2% | ₪250.5m | n/a | PE8.2x | n/a | 4.0% | ||
ININ | ₪2.87 | 8.8% | 1.6% | ₪125.7m | n/a | PS0.2x | n/a | 0% | ||
FGAS | ₪11.69 | -0.8% | 21.3% | ₪248.7m | n/a | PS7.6x | n/a | n/a | ||
ACCL | ₪1.90 | -3.2% | 144.8% | ₪306.7m | n/a | PE44.8x | n/a | 0% | ||
HIPR | ₪18.82 | 1.1% | 10.4% | ₪886.8m | n/a | PE14.9x | n/a | 1.9% | ||
INTR | ₪65.00 | 0% | 12.1% | ₪131.9m | n/a | PE14.3x | n/a | 0.8% |